Repository logo
 
Publication

Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results

dc.contributor.authorBusch, Catharina
dc.contributor.authorFraser-Bell, Samantha
dc.contributor.authorIglicki, Matias
dc.contributor.authorLupidi, Marco
dc.contributor.authorCouturier, Aude
dc.contributor.authorChaikitmongkol, Voraporn
dc.contributor.authorGiancipoli, Ermete
dc.contributor.authorRodríguez-Valdés, Patricio J.
dc.contributor.authorGabrielle, Pierre-Henri
dc.contributor.authorLaíns, Inês
dc.contributor.authorSantos, Ana Rita
dc.contributor.authorCebeci, Zafer
dc.contributor.authorAmphornphruet, Atchara
dc.contributor.authorDegenhardt, Valentin
dc.contributor.authorUnterlauft, Jan-Darius
dc.contributor.authorCagini, Carlo
dc.contributor.authorMané-Tauty, Valérie
dc.contributor.authorRicci, D'Amico Giuseppe
dc.contributor.authorHindi, Isaac
dc.contributor.authorAgrawal, Kushal
dc.contributor.authorChhablani, Jay
dc.contributor.authorLoewenstein, Anat
dc.contributor.authorZur, Dinah
dc.contributor.authorRegak, Matus
dc.date.accessioned2021-02-09T10:17:20Z
dc.date.available2021-02-09T10:17:20Z
dc.date.issued2019-09-21
dc.description.abstractThe beneficial effect of an early switch to DEX implant in DME non-responders seen at month 12 was main- tained during the second year. A later switch from anti-VEGF to steroids still provided significant improvement. Eyes continued on anti-VEGF over a period of 24 months maintained vision. A quarter of eyes, which had not improved vision at 12 months, exhibited a delayed response to treatment.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBusch, C., Fraser-Bell, S., Iglicki, M. et al. Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results. Acta Diabetol 56, 1341–1350 (2019). https://doi.org/10.1007/s00592-019-01416-4pt_PT
dc.identifier.doi10.1007/s00592-019-01416-4pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.22/16930
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.relation.publisherversionhttps://link.springer.com/article/10.1007%2Fs00592-019-01416-4pt_PT
dc.subjectRefractory diabetic macular edemapt_PT
dc.subjectAnti-VEGF therapypt_PT
dc.subjectDexamethasone implantpt_PT
dc.subjectIntravitreal therapypt_PT
dc.subjectLong- term outcomept_PT
dc.titleReal-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year resultspt_PT
dc.typejournal article
dspace.entity.typePublication
person.familyNameSantos
person.givenNameAna Rita
person.identifier.ciencia-id0911-4138-0C3A
person.identifier.orcid0000-0003-0139-0285
rcaap.rightsclosedAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationd71931b8-d869-4334-993c-ba14ad713f01
relation.isAuthorOfPublication.latestForDiscoveryd71931b8-d869-4334-993c-ba14ad713f01

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ART_Ana_Rita_Santos_5.pdf
Size:
931.61 KB
Format:
Adobe Portable Document Format